a month ago
NKTR
AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Analyst Ranking
Top 3%
#148 out of 5223 analysts
Average Return
+31.94%
Win Rate
43%62 out of 143
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-27 - 2021-03-26 | Strong Buy |
Novavax IncNVAX | +946.95% | $19.83 | $207.61 | 2020-04-24 - 2021-04-23 | Strong Buy |
Tg Therapeutics IncTGTX | +534.38% | $4.13 | $26.20 | 2022-06-13 - 2023-06-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +382.37% | $1.90 | $9.17 | 2022-05-18 - 2023-05-17 | Strong Buy |
Trevi Therapeutics IncTRVI | +245.49% | $2.88 | $9.95 | 2024-10-07 - 2025-10-06 | Strong Buy |
Mayank Mamtani Analyst Color
Get additional color on Mayank Mamtani's coverage of popular stocks
2 months ago
CYTK
4 months ago
CNTA
4 months ago
ZYME
4 months ago
CYTK
6 months ago
HROW
6 months ago
MDGL
6 months ago
CYTK
6 months ago
TGTX
6 months ago
TBPH
a year ago
MDGL
a year ago
TRVI
a year ago
CGTX
a year ago
NVAX
2 years ago
NVAX
2 years ago
TGTX
3 years ago
CBAY
3 years ago
NVAX
3 years ago
CKPT
4 years ago
ALT
Mayank Mamtani's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | 3 | Strong Buy | $22.00 | +231.83% | Initiates Coverage On | 4 days ago |
Theravance Biopharma IncTBPH | 2 | Hold | $14.00 | -2.30% | Downgrades | 18 days ago |
Nektar TherapeuticsNKTR | 4 | Strong Buy | $150.00 | +107.70% | Reiterates | a month ago |
Cytokinetics IncCYTK | 6 | Strong Buy | $108.00 | +75.04% | Maintains | 2 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $9.00 | +105.01% | Initiates Coverage On | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $42.00 | +55.21% | Maintains | 4 months ago |
Zymeworks IncZYME | 2 | Strong Buy | $40.00 | +71.53% | Reiterates | 4 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $12.00 | +184.36% | Initiates Coverage On | 4 months ago |
Novavax IncNVAX | 17 | Strong Buy | $16.00 | +66.32% | Reiterates | 4 months ago |
Harrow IncHROW | 4 | Strong Buy | $74.00 | +122.36% | Reiterates | 6 months ago |
Madrigal Pharmaceuticals IncMDGL | 10 | Strong Buy | $560.00 | +26.94% | Maintains | 6 months ago |
Tg Therapeutics IncTGTX | 12 | Strong Buy | $55.00 | +82.91% | Maintains | 6 months ago |
Actuate Therapeutics IncACTU | 1 | Strong Buy | $20.00 | +751.06% | Initiates Coverage On | 7 months ago |
Altimmune IncALT | 9 | Strong Buy | $18.00 | +438.92% | Maintains | 7 months ago |
Medicinova IncMNOV | 2 | Strong Buy | $5.00 | +220.51% | Maintains | 9 months ago |
Macrogenics IncMGNX | 2 | Hold | $3.00 | +4.90% | Maintains | 10 months ago |
Vaxart IncVXRT | 5 | Strong Buy | $2.00 | +525.00% | Maintains | a year ago |
Trevi Therapeutics IncTRVI | 3 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Lineage Cell Therapeutics IncLCTX | 2 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Denali Therapeutics IncDNLI | 2 | Strong Buy | $35.00 | N/A | Reiterates | a year ago |
Arrowhead Pharmaceuticals IncARWR | 7 | Strong Buy | $38.00 | N/A | Reiterates | a year ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $96.00 | N/A | Reiterates | a year ago |
Cognition Therapeutics IncCGTX | 3 | Strong Buy | $1.50 | N/A | Upgrades | a year ago |
Gritstone Bio IncGRTSQ | 4 | Hold | $1.00 | N/A | Downgrades | a year ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | N/A | Downgrades | 2 years ago |
Checkpoint Therapeutics IncCKPT | 3 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 4 | Strong Buy | $3.50 | N/A | Maintains | 2 years ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Intercept Pharmaceuticals IncICPT | 8 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
X4 Pharmaceuticals IncXFOR | 5 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Agenus IncAGEN | 1 | Strong Buy | $160.00 | N/A | Reiterates | 3 years ago |
Spectrum Pharmaceuticals IncSPPI | 4 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Gain Therapeutics IncGANX | 3 | Hold | $5.00 | N/A | Downgrades | 4 years ago |
Filana Therapeutics IncFLNA | 3 | Strong Buy | $44.00 | N/A | Maintains | 4 years ago |
Fortress Biotech IncFBIO | 1 | Strong Buy | $90.00 | N/A | Maintains | 4 years ago |
Inmune Bio IncINMB | 2 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $450.00 | N/A | Maintains | 4 years ago |
Korro Bio IncKRRO | 1 | Strong Buy | $10.00 | N/A | Maintains | 4 years ago |
Allena Pharmaceuticals IncALNAQ | 3 | Hold | $0.50 | N/A | Downgrades | 4 years ago |
Scorpius Holdings IncSCPX | 1 | Strong Buy | $8.00 | N/A | Maintains | 4 years ago |
Seelos Therapeutics IncSEELQ | 2 | Strong Buy | $15,360.00 | N/A | Maintains | 4 years ago |
Mustang Bio IncMBIO | 3 | Strong Buy | $4,500.00 | N/A | Maintains | 4 years ago |
Biovie IncBIVI | 2 | Strong Buy | $2,700.00 | N/A | Maintains | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 5 years ago |
Grace Therapeutics IncGRCE | 2 | Strong Buy | $96.00 | N/A | Upgrades | 6 years ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Hold | $1,440.00 | N/A | Downgrades | 6 years ago |
Galectin Therapeutics IncGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 6 years ago |
IMV IncIMVIQ | 2 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Liberty Media CorpFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 6 years ago |
Genfit SaGNFTY | 1 | Strong Buy | $34.00 | N/A | Maintains | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.